Spots Global Cancer Trial Database for Antineoplastic Drugs in Elderly Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Antineoplastic Drugs in Elderly Patients
Official Title: Population Pharmacokinetics, Effectiveness and Safety of Antineoplastic Drugs in Elderly Patients
Study ID: NCT05467189
Conditions
Study Description
Brief Summary: The purpose is to study the population pharmacokinetics, effectiveness and safety of antineoplastic drugs (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib, Imatinib, Lapatinib, etc) in elderly patients and recommend optimized dosage regimens.
Detailed Description:
Eligibility
Minimum Age: 65 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China
Contact Details
Name: Zhao Wei, Ph.D
Affiliation: Qianfoshan Hospital
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
